ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial

Monday, November 18, 2013

Submitted by

Source

Source Name: Lancet

Source URL: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2813%2961783-3/ab…

Author(s)

H Thiele, U Zeymer, F-J Neumann, M Ferenc, H-G Olbrich, J Hausleiter, A de Waha, G Richardt, M Hennersdorf, K Empen, G Fuernau, S Desch, I Eitel, R Hambrecht, B Lauer, M Bohm, H Ebelt, S Schneider, K Werdan, G Schuler

Pts with acute MI complicated by shock who were being treated with optimal medical therapy and for whom early revascularization was planned were assigned to IABP vs control. 600 patients were randomized. Death rates at 12 mos in the IABP and control groups were 52% vs 51%. Reinfarction, recurrent revascularization, stroke, and quality of life did not differ between the groups.